STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
about
The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuriesProphylactic and therapeutic functions of drug combinations against noise-induced hearing lossThe role of glucocorticoids for spiral ganglion neuron survival.Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis.Clinical and experimental advances in regeneration of spinal cord injury.A novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells.Effects of gender on gene expression in the blood of ischemic stroke patients.Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity.The role of JAK-STAT signaling within the CNS.From demyelination to remyelination: the road toward therapies for spinal cord injury.Methylprednisolone induces apoptosis by interacting with the JAK/STAT pathway in HL-60 and K-562 leukemic cells.Influence of treatment in multiple sclerosis disability: an open, retrospective, non-randomized long-term analysis.Microglia response and in vivo therapeutic potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury.Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.Protective effect of ginkgolide B against acute spinal cord injury in rats and its correlation with the Jak/STAT signaling pathway.Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.Activation of STAT1 in neurons following spinal cord injury in mice.Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system
P2860
Q26746135-5B8CF416-931D-4EFE-AD29-9EF5194C925DQ28388403-599930CD-AD3C-4C31-B5A4-2E622FDEA3A3Q30480943-41863F88-1E6E-4798-BAC5-946F12C02408Q34541013-479C9213-34E1-48EC-A2B9-CC4490FA7A79Q34591366-D025E1CE-6092-4534-80FB-31CCCC1CF0B4Q34997135-450CB965-B368-4DAA-B2C8-9D1E64400D6AQ35939168-1E28E74B-04BA-4776-B6D8-F9CBA90BB361Q35956715-7CFC6A43-7C61-4ED5-AA89-843ED4472E25Q36895415-B217186D-4943-4226-B177-0A3A7484C02CQ38366783-AFF8F31F-762E-4ED5-A9BD-D51102154ED5Q39337531-E0FAFF94-F34F-465E-BDDC-A7D11D7DAFDCQ42929708-1BFE7C14-7B41-434F-8697-4CFEA45C5F52Q46052220-5CE8C887-BB2F-41C0-AAD9-2855B99C7EDAQ48327595-4E08AB4C-A941-44FC-9EBD-370697EF723BQ53127146-6C0B8BE5-DC66-4DBA-B6DE-C09B5A6FE348Q54363020-42B55024-E6D9-498D-8A77-B8BF10B75AD9Q54568438-63944177-D0D2-421F-9BAD-583CC6C0D731Q57838184-717B83AC-BB88-4310-B20B-2A8093ED070E
P2860
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
@en
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
@nl
type
label
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
@en
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
@nl
prefLabel
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
@en
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
@nl
P2093
P2860
P1476
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
@en
P2093
Drew Michael
Jianxin Bao
Qingli Xiao
Shawei Chen
P2860
P304
P356
10.1523/JNEUROSCI.2621-08.2009
P407
P577
2009-02-01T00:00:00Z